Navigation Links
Adipose stem cell heart attack trial data published in JACC
Date:1/24/2012

San Diego Cytori Therapeutics (NASDAQ: CYTX) announced today the publication of previously reported six-month outcomes from APOLLO, the Company's European clinical trial evaluating adipose-derived stem and regenerative cells (ADRCs) in patients with acute myocardial infarction (heart attack or AMI), as Research Correspondence in the Journal of the American College of Cardiology. The APOLLO trial was a 14-patient, prospective, randomized, double-blind, placebo-controlled, feasibility trial (Phase I/IIA) evaluating autologous ADRCs extracted with the Company's proprietary Celution System for the treatment of patients suffering from acute myocardial infarction.

In the APOLLO trial all patients were treated with standard-of-care and subsequently underwent an abdominal liposuction. Each patient's adipose tissue was processed by the Celution System where ADRCs were extracted, washed and concentrated into a syringe of clinical grade cells. Within 36 hours of the myocardial infarction and no longer than 24 hours after undergoing percutaneous coronary intervention, patients received an injection of either 20 million ADRCs (n=10) or a placebo (n=4).

The publication reported:

  • Safety
    • The procedure could be safely performed in an acute setting
    • No side effects from ADRC delivery, processed using Celution
    • No increase in arrhythmias
  • Feasibility
    • Improvement in cardiac function by SPECT
    • Improvement in blood flow into the heart muscle (perfusion defect)
    • Reduction in scar formation (infarct size)

"Based on both the six and 18-month outcomes, which showed continued safety and sustained long-term benefits, we initiated ADVANCE, a pivotal, prospective, randomized, double-blind, European heart attack trial in up to 360 patients," said Christopher J. Calhoun, CEO for Cytori. "The goal of our ADRC therapy is to reduce scarring, preserve heart muscle beyond what can be salvaged with current treatments, minimize harmful remodeling, and ultimately protect patients from advancing into heart failure."

The publication, co-authored by trial investigators Drs. Henricus J. Duckers, Patrick W. Serruys, Jaco H. Houtgraaf at Thoraxcenter, Erasmus University Hospital and others, reported the following:

  • The percentage of left ventricle (LV) infarcted was reduced by 52% (31.6 5.3% to 15.3 2.6% at six-month follow-up, p=0.002) in the ADRC-treated patients, as opposed to no change in the placebo-treated AMI patients (24.7 9.2 % vs. 24.7 4.1%). The difference between the groups was not statistically significant.

  • There was a significant improvement of the perfusion defect in ADRC-treated patients from 16.9 2.1% to 10.9 2.4% at six-month follow-up (change of 6.0%, p=0.004) as compared to a deterioration in the placebo group by 1.8% (15.0 4.9% to 16.8 4.3%).

  • Left ventricular ejection fraction (LVEF), measured by SPECT, improved with an absolute difference of +5.7% (p=0.114). In ADRC treated patients, LVEF improved by 4% (52.1% to 56.1%), as compared to a deterioration of 1.7% in the placebo group (52.0% to 50.3%).

"The advantage of adipose tissue as a cell source is that it allows physicians to get a meaningful dose of a patient's own cells at the point-of-care when using the Celution System without cell culture or use of donor cells," said Dr. Duckers, lead author of the paper. "We believe delivering cells within the first 24 to 36 hours takes advantage of the body's signaling and initiates the repair process before irreparable damage occurs."

Cytori is currently preparing the full 18 month data set for publication.


'/>"/>

Contact: Megan McCormick
mmccormick@cytori.com
858-875-5279
Cytori Therapeutics
Source:Eurekalert

Related biology news :

1. Fish oil during pregnancy does not protect against excessive adipose tissue development
2. The amount of adipose tissue should be taken into account in the fight against obesity
3. Cytori reports benefit of adipose-derived regenerative cells in spinal disc model
4. Hearty bacteria help make case for life in the extreme
5. The microbiome and disease: Gut bacteria influence the severity of heart attacks in rats
6. Viagra against heart failure: Researchers at the RUB and from Rochester throw light on the mechanism
7. New scanning strategy could help develop heart disease treatments
8. New Columbia engineering technique diagnoses non-periodic arrhythmias in a single heartbeat
9. Environment and diet leave their prints on the heart
10. Restricted calorie diet improves heart function in obese patients with diabetes
11. New design for mechanical heart valves
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... -- Today HYPR Corp. , leading innovator in ... the HYPR platform is officially FIDO® Certified . ... that empowers biometric authentication across Fortune 500 enterprises and ... 15 million users across the financial services industry, however ... suites and physical access represent a growing portion of ...
(Date:3/30/2017)... 30, 2017  On April 6-7, 2017, Sequencing.com will ... hackathon at Microsoft,s headquarters in ... focus on developing health and wellness apps that provide ... the Genome is the first hackathon for personal ... largest companies in the genomics, tech and health industries ...
(Date:3/28/2017)... The report "Video Surveillance Market ... Storage Devices), Software (Video Analytics, VMS), and Service (VSaaS, ... to 2022", published by MarketsandMarkets, the market was valued ... to reach USD 75.64 Billion by 2022, at a ... year considered for the study is 2016 and the ...
Breaking Biology News(10 mins):
(Date:4/24/2017)... 2017  Dante Labs announced today the offer of whole ... $900). While American individuals have been able to access WGS ... access WGS below EUR 1,000. The sequencing includes ... information to make informed decisions about disease monitoring, prevention, nutrition, ... ...
(Date:4/21/2017)... Storrs, Conn. (PRWEB) , ... April 21, 2017 ... ... Innovations (CI) and Webster Bank, today announced first round funding to three startups ... to provide early-stage financial support to new business startups affiliated with UConn. , ...
(Date:4/21/2017)... ... April 21, 2017 , ... Frederick Innovative Technology Center, Inc. ... bio and technology start-ups, is hosting “Celebration Friday” (a festive gathering highlighting client ... with libations and networking at 3:30 p.m. at FITCI’s 4539 Metropolitan Court location, ...
(Date:4/20/2017)... ... April 20, 2017 , ... ... their strategic partnership to offer a full spectrum of digital security goods and ... of biometric products and the ground-breaking proactive cybersecurity services and products through Assured ...
Breaking Biology Technology: